News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
Format:Category:
1 Results– filtered by:#Qtas
Interviews
Qtas: In Search of the One Cell
From Munich quantum research to personalized medicine: Qtas, a startup founded in 2025 by Robin Allert, Karl Briegel, and Nick von Grafenstein, develops technology that makes extremely rare tumor cells in blood samples visible and analyzable. In the interview, CEO Robin Allert explains how personal experiences and quantum sensing formed the foundation for the company.
24.07.26
5 Min.